Biomerica
BMRA
22 hedge funds and large institutions have $11M invested in Biomerica in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.
109% more call options, than puts
Call options by funds: $486K | Put options by funds: $232K
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
8% more capital invested
Capital invested by funds: $10.2M → $11M (+$806K)
1.28% less ownership
Funds ownership: 20.75% → 19.47% (-1.3%)
15% less funds holding
Funds holding: 26 → 22 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$57.9K |
| 2 |
EP
Eudaimonia Partners
Winchester,
Tennessee
|
+$45.2K |
| 3 |
HWA
HCR Wealth Advisors
Los Angeles,
California
|
+$41.1K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$15.2K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$12.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$419K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$73K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$58K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$43K |
| 5 |
Morgan Stanley
New York
|
-$20.5K |
BMRA Hedge Fund Activity: Q3 2021 in Review
22 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q3 2021, worth a combined $11M — up 7.9% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BMRA and 3 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was BlackRock, adding an estimated $57.9K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $419K sold.
- 22 institutional investors held Biomerica (BMRA) as of Q3 2021, down from 26 in Q2 2021.
- Funds reported $11M of Biomerica stock for Q3 2021, up 7.9% quarter-over-quarter.
- 3 funds opened new Biomerica positions in Q3 2021 and 7 closed out, a net change of -4 holders.
- The largest Biomerica buyer in Q3 2021 was BlackRock, an estimated $57.9K added.
- The largest Biomerica seller in Q3 2021 was GSA Capital Partners, an estimated $419K sold.
Based on aggregated 13F filings for Q3 2021.